Worth reading
11Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Neutral
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Definitive
How definitive the wording is.This transaction
Mutual Termination of the Share Transfer Agreement for アスリートメッド株式会社Disclosing companyADR Biomedical Holdings Inc.
Contract DateOctober 2025
Execution Date / Effective DateThe share transfer will not be completed, and the agreement will be terminated by mutual agreement.
Impact on Business Performance
The transaction will have no impact on the Company's financial results.
| Item | Details |
|---|---|
| Transaction name | Mutual Termination of the Share Transfer Agreement for アスリートメッド株式会社 |
| Name of the Subject Company | アスリートメッド株式会社 |
| Impact on Business Performance | The transaction will have no impact on the Company's financial results. |
| Contract Date | October 2025 |
| Execution Date / Effective Date | The share transfer will not be completed, and the agreement will be terminated by mutual agreement. |
Items this document does not state (27)
Counterparty nameBusiness Description of the Subject CompanyLocation of the Subject CompanyCapital Stock of the Subject CompanyDate of Establishment of the Subject CompanyNet Sales of the Subject CompanyOperating Profit of the Subject CompanyNet Income of the Subject CompanyNet Assets of the Subject CompanyAcquisition priceExpenses other than the acquisition priceType of ConsiderationMerger ratio/share exchange ratioTender offer priceMinimum number of shares to be purchasedTender offer periodNumber of shares acquiredVoting rights ownership percentageFunding arrangementsGoodwill amountAmount of extraordinary income (loss)Date of board resolutionValuation methodologyIndependent valuation institutionSpecial CommitteeConditions Precedent to ExecutionManagement structure after acquisition
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Following a detailed review and discussions, the Company determined that it needed to carefully reassess the business viability and profitability of アスリートメッド株式会社 and their alignment with the Company's future growth strategy.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.